In conclusion, these observations suggest that a diagnostic gene panel tests for those with pediatric PAH, PAVMs, and/or cutaneous telangiectases should include GDF2 and by association, BMP10. This evidence concerns the gene BMP10 and pulmonary arterial hypertension.